All into Account
Equity Strategy: USD strength - equity implications; The barbell of Defensives and Energy remain our key preferences
23 Oct 2023
Speaker: Mislav Matejka, CFA, Head of Global Equity Strategy In addition to the move up in energy prices and elevated bond yields, renewed USD strength is another factor that the equity market needs to digest. Last October, USD peak coincided with the equity trough, and the more mixed equity performance in the past few months is coinciding with USD bottoming. Almost always in the past, when USD is strengthening, global equities have been under pressure. Our FX team is bullish on the USD over the next 3-6 months, vs all major crosses. If that comes to pass, equities in general could stay under pressure. Regionally, a stronger USD has typically meant the outperformance of Japan, Switzerland and the UK, in local currency, given their large export exposures. When assessing the performances in common currency, US equities are the top performers in times of USD strength, even with a headwind to the exporters, and Japan stays the outperformer, in the regional context. EM is an underperformer, and it is Eurozone that moves to the bottom of the pecking order. EM are lagging DM this year by 10%+, and from our equity strategy perspective, we remain cautious on EM. Broadly, in terms of sector tilts, we continue advising a barbell of commodities – OW Energy – together with a low beta exposure, such as Staples and Utilities, and that could track even if bond yields keep going higher in the near term. European Healthcare could be interesting, as well, as it tended to work well with a strong USD. Thematically, we maintain our longstanding preference for FTSE100 over FTSE250 that we initiated in November ’21. In terms of equity market levels, our index target of 4150 for SX5E has not changed over the last 12 months, since it was initiated. Stocks are at present below it, but we expect continued undershooting of the targets in the near term. This podcast was recorded on 22 October 2023. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4540044-0 for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2023 JPMorgan Chase & Co. All rights reserved.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View